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Background: Pneumonia is a leading cause of morbidity and mortality in children worldwide; however,
its diagnosis can be challenging, especially in settings where skilled clinicians or standard imaging are
unavailable. We sought to determine the diagnostic accuracy of lung ultrasound when compared to
radiographically-conﬁrmed clinical pediatric pneumonia.
Methods: Between January 2012 and September 2013, we consecutively enrolled children aged 2e59
months with primary respiratory complaints at the outpatient clinics, emergency department, and
~ o in Lima, Peru. All participants underwent
inpatient wards of the Instituto Nacional de Salud del Nin
clinical evaluation by a pediatrician and lung ultrasonography by one of three general practitioners. We
also consecutively enrolled children without respiratory symptoms. Children with respiratory symptoms
had a chest radiograph. We obtained ancillary laboratory testing in a subset.
Results: Final clinical diagnoses included 453 children with pneumonia, 133 with asthma, 103 with
bronchiolitis, and 143 with upper respiratory infections. In total, CXR conﬁrmed the diagnosis in 191
(42%) of 453 children with clinical pneumonia. A consolidation on lung ultrasound, which is our primary
endpoint for pneumonia, had a sensitivity of 88.5%, speciﬁcity of 100%, and an area under-the-curve of
0.94 (95% CI 0.92e0.97) when compared to radiographically-conﬁrmed clinical pneumonia. When any
abnormality on lung ultrasound was compared to radiographically-conﬁrmed clinical pneumonia the
sensitivity increased to 92.2% and the speciﬁcity decreased to 95.2%, with an area under-the-curve of 0.94
(95% CI 0.91e0.96).
Conclusions: Lung ultrasound had high diagnostic accuracy for the diagnosis of radiographicallyconﬁrmed pneumonia. Added beneﬁts of lung ultrasound include rapid testing and high inter-rater
agreement. Lung ultrasound may serve as an alternative tool for the diagnosis of pediatric pneumonia.
© 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction

2.2. Clinical diagnosis

Pneumonia is a leading cause of death in children worldwide. It
is responsible for 120 million episodes and 1 million deaths each
year in children aged <5 years [1,2]. Despite a decrease in child
mortality in the past 20 years, the proportion of pneumonia deaths
has remained constant at approximately 20% [3]. In low resource
settings, where skilled providers are not widely available, the
World Health Organization (WHO) developed a case management
algorithm for the treatment of pneumonia. This involved training
community health workers to identify respiratory signs and
symptoms, centered on cough, difﬁculty breathing, respiratory rate
and danger signs, for diagnosis, treatment, and referral [5]. While
this algorithm achieved important mortality reductions after
implementation [6], multiple studies thereafter have shown that it
lacks speciﬁcity [7e9]. A high false positive rate has resulted in
overuse of antibiotics and improper therapy for children with acute
bronchospasm that may instead require bronchodilators.
Pediatric pneumonia is a heterogeneous disease with bacterial
and viral causes. Additionally, there is a large overlap with bronchiolitis and reactive airways disease. Therefore, the diagnosis of
pneumonia can be challenging and requires integration of a variety
of diagnostic tools [9,10]. In low resource settings, previous studies
have tested additional, non-respiratory, diagnostic features, such as
fever [10] and oxygen saturation [11,12]. But when resources are
available, imaging is an important adjunct [13]. In fact, the American Academy of Pediatrics endorsed chest X-ray (CXR) as the imaging modality of choice for complicated or ambiguous cases [10].
However, CXR has its own disadvantages including radiation
exposure, high inter-observer variability [14], and lack of impact on
clinical outcome [15].
Lung ultrasound (LUS) is an emerging diagnostic tool for
pneumonia in both adults [16] and children [17]. It also has many
advantages for pediatric respiratory disease in low resource settings, including portability, rapid and repeat testing, no ionizing
radiation, and ease of use [18e20]. We sought to evaluate the
diagnostic accuracy of LUS as a point-of-care diagnostic tool for
pediatric pneumonia in a tertiary care setting in Lima, Peru.

Clinical assessment included a history and physical exam performed by a pediatrician. Pediatricians on service provided a
diagnosis following standard of care with input from international
clinical guidelines (Table 1) [23e25]. An anteroposterior CXR was
obtained for all children with respiratory symptoms. Lateral view
CXRs were not obtained because they were not consistent with
clinical practice in our setting. CXR used a scanner with
4800  4800 dots-per-inch resolution for CXR image digitation.
Films were digitized and sent to a third party reading group of three
study radiologists. We did not obtain a CXR on children without
respiratory symptoms.

2. Materials and methods
2.1. Study design
Between January 2012 and September 2013, we consecutively
enrolled children with respiratory symptoms in the Emergency
Department, General Pediatric Wards, and Outpatient Clinics at the
~ o; a large children's hospital
Instituto Nacional de Salud del Nin
treating more than 170,000 children annually, in Lima, Peru. Inclusion criteria were children aged 2e59 months and the presence
of respiratory symptoms. Exclusion criteria were: chronic lung
disease excluding asthma, signiﬁcant cardiac disease, and need for
mechanical ventilation. We also enrolled children of a similar age
range without respiratory complaints and acute non-respiratory
illnesses (fever, vomiting or diarrhea) at the same institution.
These children were usually those presenting to the hospital for
well-child visits or siblings of child participants recruited into the
study. We described detailed methods about study procedures
elsewhere [21]. Of note, we amended the original protocol to allow
for an increase in sample size. We followed STARD guidelines for
the reporting of diagnostic accuracy [22]. The study was approved
by the Institutional Review Board committees of the Instituto
~ o (Lima, Peru), A.B. PRISMA (Lima, Peru),
Nacional de Salud del Nin
and the Johns Hopkins School of Medicine (Baltimore, USA).

2.3. Lung ultrasound imaging
All participants underwent a complete LUS evaluation using a
MicroMaxx® portable ultrasound machine (Sonosite, Bothwell,
WA) with a HFL38/13-6 MHz linear transducer. This device is
approximately the size of a 13” laptop computer and used at the
bedside as a point-of-care tool. One of three general practitioners
(LEE, MAC, and JMC) performed LUS after completing a 7-day
standardized training protocol [21] based on international recommendations [26]. Both conduct and interpretation of LUS ﬁndings
were performed independent of clinical evaluation or radiographic
ﬁndings. LUS was conducted on almost all children who had CXR as
well as on all children without respiratory symptoms (Fig. 1).
2.4. Imaging interpretation
Interpretation CXR and LUS images was performed at a later
date by three board-certiﬁed pediatric radiologists (PCC, EAM, and
JB) and three general practitioners (LEE, MAC, and JMC), respectively. These groups were blinded to clinical information and results from the alternative imaging modality. We used standardized
protocols for interpretation of both CXR [14] and LUS [26]. We
deﬁned radiographic pneumonia as the presence of a lobar
consolidation with or without a pleural effusion (Table 1). Pneumonia on LUS was deﬁned as the identiﬁcation of artifacts consistent with lobar consolidation or patchy lobar consolidation, if it
occupied more than one intercostal space in vertical view, or small
consolidation with a pleural effusion (Table 1). We did not consider
the isolated ﬁndings of interstitial changes on LUS or CXR as positive for pneumonia. Agreement by two out of three readers was
required for ﬁnal diagnosis.
2.5. Laboratory assessment
We conducted laboratory testing in a subset of participants to
offer additional objective data. Complete blood counts and blood
cultures were obtained in a subset of 361 and 137 children,
respectively. Serum or plasma levels of procalcitonin (PCT) were
measured in a convenience sample of 259 children. Batched samples were maintained at 20  C until tested in a reference laboratory. PCT levels were measured using the Kryptor
chemiluminescence immunoassay (BRAHMS, Hennigsdorf, Germany) according to manufacturer speciﬁcations. The inter-assay
coefﬁcient of variation was <10%, and the functional sensitivity of
the assay was 0.06 ng/mL. Pharyngeal swabs were analyzed for
viruses and bacteria in a convenience sample of 251 children.
Nucleic acid extraction for viral testing was accomplished utilizing
the Arrow Viral NA kit (Diasorin Inc., Stillwater, MN), while bacterial extraction utilized the MagNA Pure LC with DNA Isolation Kit I
(Roche Diagnostics, Indianapolis, IN). For viral testing, respiratory
virus controls were utilized in each run (NATrol Respiratory

L.E. Ellington et al. / Respiratory Medicine 128 (2017) 57e64

59

Table 1
Guidelines for clinical diagnosis and deﬁnitions and grading system for lung ultrasound and chest radiograph.
Clinical diagnoses
Pneumonia

Difﬁculty breathing as described by tachypnea, chest indrawing, nasal ﬂaring, or grunting; history of fever, cough, chest pain or abdominal pain;
adventitious lung sounds, including rales, rhonchi, crackles, or diminished sounds. Associated CXR ﬁndings of interstitial abnormalities or
consolidation as reviewed by hospital clinician or on-site radiologist at time of diagnosis [3]. Severity was assessed by presence of chest indrawing,
seizures, lethargy, or unconsciousness [4].
Asthma
Presence of wheeze or difﬁculty breathing on physical exam, history of wheeze and responsive to bronchodilators [5]. Response to
bronchodilators assessed clinically without formal pulmonary function testing.
Bronchiolitis
Less than 18 months of age; presence of wheeze or coarse breath sounds, difﬁculty breathing, and viral symptoms (cough, rhinorrhea); not
responsive to bronchodilators if attempted [24].
Upper respiratory
Associated with nasal secretions, nasal congestion, sore or red throat or hoarseness without evidence of lower airways involvement (tachypnea
infection
and abnormal lung sounds on exam).
Lung ultrasound ﬁndings
Lung sliding
Rhythmic movement of pleural line with respiration. It represents sliding of the visceral pleura against the parietal pleura.
A-lines
Horizontal lines equally spaced from pleural line, representing artifact generated by subpleural air, a normal ﬁnding.
B-lines
Vertical lines arising from pleura and extending to base of the image.
Pleural abnormality
Disruption of pleural line.
Consolidation
Hypoechoic circumscribed disruption of pleural line extending inferiorly and may contain any of the following; Air bronchogram, Shred sign,
Pleural effusion.
Air bronchogram
Punctate or branching hyperechoic images reﬂecting airways made visible by surrounding ﬂuid/inﬂammation
Shred sign
Irregular border of consolidation
Pleural effusion
Anechoic space between visceral and parietal pleura.
Sonographic grading
Lung consolidation
Small
Consolidation contained within one intercostal space and extending just below pleural line.
Large
Consolidation extends to more than 1 intercostal space, extends beyond the pleural line, and may be associated with a pleural effusion.
Interstitial abnormality
Focal
Multiple B lines (3) present in single view or unilaterally.
Diffuse
Multiple B lines (3) present bilaterally.
Radiographic grading
Lung consolidation
Alveolar pneumonia: dense, ﬂuffy consolidation of a portion of a lobe or entire lung. Often contains air bronchograms and may be associated with
pleural effusion.
Interstitial
Linear and patchy densities in a lacy pattern involving both lungs, featuring peri-bronchial thickening and multiple areas of atelectasis. Lung
abnormality
inﬂation is normal to increased.

Validation Panel 3, Zeptometrix Corporation, Buffalo, NY). Reverse
Transcription polymerase chain reaction/Electrospray ionization
mass spectrometry (RT-PCR/ESI-MS, Abbott Molecular, Des Plaines,
IL) was performed for viral and bacterial pathogens with Respiratory Virus Surveillance 2.5 kit and the Bacterial Antibiotic Candida
kit. Positive detection were deﬁned as reactions identiﬁed by RTPCR/ESI-MS as having a Q score >0.9.
2.6. Biostatistical methods
The primary goal of our analysis was to establish the diagnostic
accuracy of sonographically-conﬁrmed pneumonia when
compared to radiographically-conﬁrmed clinical pneumonia as the
reference standard. This comparison was conducted in child participants with respiratory ﬁndings that were diagnosed with clinical pneumonia by a study physician, and had both CXR and LUS
conducted as part of the study. We focused on clinical pneumonia
only because asthma, bronchiolitis and upper respiratory infection
had low rates of consolidation on CXR. We deﬁned positive sonographic ﬁndings as either ﬁnding a consolidation or any abnormality on LUS. Any abnormality on LUS was included to show that
there was a difference in diagnostic accuracy between consolidation and any abnormality on LUS, when compared to
radiographically-conﬁrmed clinical pneumonia. Diagnostic accuracy was measured using positive predictive value (PPV), negative
predictive value (NPV), sensitivity, speciﬁcity and the C-statistic as
a measure of area under the Receiving Operator Characteristic
curve. We analyzed continuous variables as means using analysis of
variance, and categorical variables as proportions using chi-square
or Fisher exact tests, as appropriate. Inter-rater agreement among
readers was determined using the kappa coefﬁcient. We conducted
statistical analyses in R (www.r-project.org) and STATA version 13
(StatCorp, College Station, Texas).

3. Results
3.1. Participant characteristics
From January 2012 to September 2013, 1428 children were
assessed for eligibility (Fig. 1). Of those, 1062 (74%) children underwent LUS. Upon initial assessment, 128 children were found to
be ineligible due to age, and presence of cardiac or chronic respiratory disease, and 163 children without respiratory symptoms
were found to have an acute non-respiratory illness upon further
evaluation. Additionally, 76 ultrasounds were not obtained due to
time constraints or parents refused. Median age was 19 months and
57% were male. The ﬁnal clinical diagnoses were as follows: 453
had clinical pneumonia, 133 had asthma, 103 had bronchiolitis, 143
had an upper respiratory infection, and 230 were children without
respiratory symptoms (Table 2). CXR identiﬁed abnormalities
consistent with pneumonia in 360 (79%) children, and 191 (42%)
were found to have consolidations and 169 (37%) had an interstitial
abnormality.

3.2. Inter-reader agreement
For LUS, kappa coefﬁcients for agreement among readers was
0.65 (95% CI 0.61e0.66) overall, 0.73 (0.70e0.74) for a normal lung
ultrasound, 0.38 (0.27e0.41) for interstitial abnormalities, and 0.77
(0.75e0.78) for lung consolidation. Medium and large consolidation ﬁndings yielded a kappa coefﬁcient of 0.87 (0.86e0.89) and
small consolidation yielded a kappa coefﬁcient of 0.77 (0.74e0.81).
For CXR, kappa coefﬁcients for agreement among readers was 0.37
(95% CI 0.34e0.40) overall, 0.40 (0.37e0.42) for normal chest
radiograph, 0.20 (0.16e0.23) for interstitial abnormalities, and 0.51
(0.48e0.58) for lung consolidation.
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Fig. 1. Flowchart of study participants.

3.3. Imaging characteristics
A total of 1062 ultrasounds were available for review. Among
children without respiratory symptoms, none had lung consolidation, and 11 (1%) had an interstitial abnormality. Of the 832 participants with respiratory symptoms, 414 (50%) had a sonographic
lung consolidation and 530 (64%) had any abnormality (Table 3). On
average, LUS took less than 10 min to perform; 5.5 ± 2.1 min in
controls compared to 8.2 ± 3.1 min in children with pneumonia
(p < 0.001). We summarized characteristics of LUS ﬁndings in
Table 2. A total of 832 CXRs were available for review. Of these, 221
(26%) had a lobar consolidation and 264 (32%) had interstitial
abnormality.
3.4. Diagnostic performance
Consolidation on lung ultrasound had a sensitivity of 88.5%,
speciﬁcity of 100%, and AUC of 0.94 (95%CI 0.92e0.97) when
compared with radiographically-conﬁrmed clinical pneumonia
(Table 4). Any abnormality on lung ultrasound had a sensitivity of
92.2%, speciﬁcity of 95.2%, and AUC of 0.94 (95% CI 0.91e0.96) with
compared with radiographically-conﬁrmed clinical pneumonia
(Table 5).
3.5. Laboratory ﬁndings
We summarized differences in ancillary laboratory data by ﬁnal
diagnosis status (Table 6). Procalcitonin levels supported our clinical deﬁnitions of pneumonia and bronchiolitis, with highest levels

in children with pneumonia. Children with bronchiolitis were more
likely to have respiratory syncytial virus isolated on a pharyngeal
swab when compared to other groups. Streptococcus pneumoniae
was present in over half of all participants, with no difference found
between children with or without respiratory symptoms. There
were no differences in demographic variables like age and sex between those with and without ancillary laboratory data (data not
shown).
4. Discussion
Our study supports the use of point-of-care lung ultrasound as a
reliable and accurate method of diagnosing radiographicallyconﬁrmed clinical pediatric pneumonia. LUS averaged less than
10 min to perform with high inter-reader agreement. Moreover,
there is a high diagnostic accuracy between identiﬁcation of
consolidation on LUS and radiographically-conﬁrmed clinical
pneumonia in children.
Two recent meta-analyses by our group also demonstrated high
accuracy of LUS for the diagnosis of pneumonia in adults [16] and
children [17], however, these analyses were limited by small sample sizes and heterogeneity among studies, decreasing the overall
power. Moreover, ﬁve of the eight studies focused on hospitalized
or critically ill children [28,30,32] or neonates [29,31], and therefore lacked generalizability in an outpatient or emergency room
setting. Additionally, sonographers read the LUS at time of clinical
evaluation and therefore were not blinded to clinical information.
Our study has several strengths and contributes novel and
important information. We enrolled >1000 children aged under
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Table 2
Demographic information and clinical characteristics according to study group. Tachycardia was deﬁned as a heart rate 190 beats/minute in children aged <12 months
and heart rate 140 beats/minute in children aged 12 months. Tachypnea was deﬁned as respiratory rate >50 breaths/minute for children aged 2e11 months and respiratory
rate >40 breaths/minute for children aged 12 months.
Characteristics

Children without respiratory symptoms Pneumonia
(n ¼ 230)
(n ¼ 453)

Demographic characteristics
Age in months, mean (SD)
41.3 (15.2)
Number < 12 months (%)
30 (13)
Number of boys (%)
117 (51)
Clinical characteristics
Symptoms, n (%)
Cough
0 (0)
Difﬁculty breathing
0 (0)
Rhinorrhea
0 (0)
Fever
0 (0)
Diarrhea
0 (0)
Chest indrawing, n (%)
0 (0)
Temperature, mean (SD)
36.4 (0.4)
Number with 38.0  C (%)
1 (0)
Heart Rate
Infants, mean (SD)
122 (14)
Children, mean (SD)
107 (10)
Number with tachycardia (%)
3 (1)
Respiratory Rate
Infants, mean (SD)
29 (4)
Children, mean (SD)
23 (3)
Number with tachypnea (%)
1 (0)
Oxyhemoglobin Saturation (SpO2) %, 99 (1)
mean (SD)
1 (0)
Number with SpO2 <95% (%)
Number with SpO2 <92% (%)
1 (0)
Auscultation ﬁndings, n (%)
Normal
230 (100)
Wheezes
0 (0)
Crackles
0 (0)
Decreased breath sounds
0 (0)
Rhonchi
0 (0)

Asthma
(n ¼ 133)

Bronchiolitis
(n ¼ 103)

Upper respiratory infection
(n ¼ 143)

P
Value

20.0 (14.6)
168 (37)
258 (57)

30.4 (18.2)
33 (25)
87 (65)

10.1 (10.1)
77 (75)
46 (35)

24.7 (16.9)
44 (31)
88 (62)

<0.001
<0.001
0.058

453 (100)
416 (92)
376 (83)
348 (77)
96 (21)
203 (45)
36.9 (0.7)
48 (11)

130 (98)
118 (89)
107 (80)
69 (52)
19 (14)
48 (36)
36.9 (0.6)
9 (7)

103 (100)
91 (88)
83 (81)
57 (55)
23 (22)
48 (46)
36.8 (0.6)
8 (8)

138 (97)
71 (50)
123 (86)
55 (38)
16 (11)
1 (1)
36.7 (0.6)
8 (6)

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

138 (17)
129 (18)
89 (20)

127 (19)
127 (17)
22 (17)

135 (17)
129 (18)
7 (7)

133 (15)
114 (16)
8 (6)

<0.001

45 (11)
39 (11)
203 (45)
96 (3)

46
36
43
96

44
42
42
97

35
27
13
99

47 (10)
175 (39)

18 (14)
51 (38)

7 (7)
23 (22)

1 (1)
10 (7)

<0.001

2 (0)
200 (44)
335 (74)
80 (19)
157 (35)

1 (1)
100 (75)
53 (40)
13 (10)
42 (32)

0 (0)
65 (63)
50 (49)
4 (4)
46 (45)

74 (52)
8 (6)
7 (5)
1 (1)
9 (6)

<0.001
<0.001
<0.001
<0.001
<0.001

(13)
(11)
(32)
(3)

(13)
(13)
(41)
(2)

(11)
(6)
(9)
(2)

<0.001

Table 3
Lung ultrasound diagnosis and characteristics.
Final ultrasound diagnosis

Children without Respiratory Symptoms Pneumonia
(n ¼ 230)
(n ¼ 453)

Asthma
(n ¼ 133)

Bronchiolitis
(n ¼ 103)

Upper respiratory infection
(n ¼ 143)

P
Value

Procedure time in minutes,
mean (SD)
Normal ultrasound, n (%)
Large Consolidation
Shred sign
Air Bronchogram
Pleural Abnormalities
Pleural Effusion
Interstitial Findings
Small Consolidation
Shred sign
Air Bronchogram
Pleural Abnormalities
Pleural Effusion
Interstitial Findings
Focal Interstitial syndrome
Diffuse Interstitial syndrome
Pleural abnormalities only

5.5 (2.1)

8.2 (3.1)

7.2 (2.5)

7.5 (2.6)

5.9 (4.2)

<0.001

219 (95)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
9 (4)
1 (0)
1 (0)

93 (21)
127 (28)
24 (19)

67 (50)
3 (2)
0 (0)

36 (35)
8 (8)
2 (25)

107 (75)
0 (0)
0 (0)

<0.001
<0.001
0.81

23 (18)
22 (17)

2 (67)
1 (33)

3 (38)
1 (13)

0 (0)
0 (0)

0.03
0.64

175 (39)
35 (20)

46 (35)
0 (0)

41 (40)
5 (12)

15 (10)
7 (47)

<0.001
<0.001

59 (34)
1 (1)

18 (19)
1 (2)

14 (34)
0 (0)

2 (13)
0 (0)

0.34
0.60

43 (9)
9 (2)
6 (1)

8 (6)
5 (4)
4 (3)

10 (10)
6 (6)
2 (2)

13 (9)
4 (3)
4 (3)

0.09
0.02
0.26

Table 4
Deﬁnitions and values for analysis of diagnostic Accuracy.
True positive

True negative

Test

Total
population

True
positive

True
negative

False
positive

False
negative

Radiographically-conﬁrmed clinical
pneumonia
Radiographically-conﬁrmed clinical
pneumonia

Children without Respiratory
Symptoms
Children without Respiratory
Symptoms

Consolidation on lung
ultrasound
Any abnormality on lung
ultrasound

421

169

230

0

22

421

176

219

11

15

62
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Table 5
Analysis of diagnostic Accuracy.
Analysis

PPV

NPV

Sensitivity

Speciﬁcity

AUC (95% CI)

Radiographically-Conﬁrmed Clinical Pneumonia vs. ﬁnding a consolidation on lung ultrasound
Radiographically-Conﬁrmed Clinical Pneumonia vs. ﬁnding any abnormality on lung ultrasound

100
94.1

91.3
93.6

88.5
92.2

100
95.2

0.94
0.94

(0.92e0.97)
(0.91e0.96)

Table 6
Laboratory evaluation in subset of participants.
Children without respiratory symptoms Pneumonia
Blood cell count
Sample size
54
Hemoglobin (mg/dl), mean (SD)
10.9 (1.3)
Number with <11 mg/dL (%)
26 (49)
Platelets x 103/L, mean (SD)
420 (136)
3
White blood cells x 10 /L, mean (SD) 11.9 (5.5)
Number with >17  103/L (%)
8 (15)
Throat swabs result
Sample size
32
Respiratory virus, n (%)
Any positive virus
4 (13)
Viral etiology
Respiratory Synctitial Virus
0 (0)
Adenovirus
3 (10)
Parainﬂuenza 1-3
0 (0)
Metapneumovirus
1 (3)
Inﬂuenza virus
0 (0)
Coronavirus
0 (0)
Bacteria and Candida
Any positive
32 (100)
Microorganism etiology
Streptococcus pneumoniae
18 (56)
Candida albicans
2 (6)
Haemophilus inﬂuenzae
1 (3)
Moraxella catarrhalis
1 (3)
Neisseria meningitidis
1 (3)
Procalcitonin, ng/ml
Sample size
28
Median (IQR)
0.01 (0.00e0.03)
Geometric mean (95% CI)
0.03 (0.03e0.04)

Asthma

Bronchiolitis

Upper respiratory infection P value

138
10.6 (1.3)
56 (41)
414 (146)
11.7 (5.1)
20 (15)

54
10.8 (1.7)
26 (48)
405 (124)
13.8 (6.7)
13 (24)

49
10.8 (1.4)
19 (39)
460 (130)
13.0 (6.0)
7 (15)

66
10.7 (1.4)
29 (44)
421 (136)
13.1 (5.0)
16 (25)

32

41

46

50

29 (35)

18 (44)

23 (50)

11 (22)

0.002

12 (18)
6 (10)
5 (9)
5 (9)
2 (4)
0 (0)

8
6
2
1
1
0

(26)
(21)
(8)
(4)
(4)
(0)

14 (38)
1 (4)
5 (18)
2 (8)
0 (0)
2 (8)

4
4
1
1
2
0

<0.001
0.45
0.07
0.77
0.79
0.04

79 (96)

36 (88)

42 (91)

50 (100)

0.03

52 (63)
6 (7)
6 (7)
2 (2)
1 (1)

27 (66)
2 (5)
0 (0)
0 (0)
1 (2)

30 (65)
9 (20)
2 (4)
1 (2)
1 (2)

33 (66)
7 (14)
2 (4)
1 (2)
0 (0)

0.91
0.11
0.45
0.89
0.80

(9)
(9)
(3)
(3)
(5)
(0)

113
50
27
41
0.14 (0.06e0.55) 0.06 (0.04e0.08) 0.06 (0.04e0.09) 0.06 (0.04e0.11)
0.19 (0.15e0.25) 0.07 (0.06e0.09) 0.07 (0.05e0.09) 0.08 (0.06e0.10)

ﬁve years and performed all testing in a busy tertiary care hospital
in a resource-limited setting, suggesting that LUS can be realistically implemented in high-volume clinical settings without major
disruptions to work ﬂow. To our knowledge, this study is the ﬁrst to
examine reproducibility of LUS between multiple readers, using a
standardized approach for the conduct of LUS. We provided speciﬁc
details of sonographic ﬁndings, separating minimal pleural abnormalities and interstitial B-lines from large consolidations. Furthermore, we performed LUS evaluation on participants with a breadth
of diverse respiratory pathologies including a group of children
without respiratory symptoms. This differs from prior research that
only focused on pneumonia without including healthy children or
those with other respiratory disease processes, with the exception
of Caiulo et al. who also studied bronchiolitis [33]. While not part of
the reference standard for diagnosis, ancillary laboratory testing
provided additional conﬁdence to our diagnoses. Procalcitonin has
previously been shown to be elevated in bacterial disease [34] and
was highest in children with radiographically-conﬁrmed pneumonia when compared to children who did not. The proportion of
children with respiratory syncytial virus was greatest among children with bronchiolitis than among those with pneumonia, which
is consistent with previous epidemiologic studies [24]. However, a
limitation to the use of pharyngeal swabs is evident because there
we did not ﬁnd a no difference in the prevalence of S. pneumoniae
between children with or without respiratory symptoms.
Our study has some potential shortcomings. First, we did not
have computerized tomography (CT) scan on all children with

0.79
0.74
0.28
0.08
0.26

<0.001
<0.001

respiratory ﬁndings but standard of care would have not directed
the use of CT scans to diagnose pneumonia in children. We used
radiographically-conﬁrmed clinical pneumonia as our gold standard, despite its limitations, which we believe is the safest alternative to the current gold-standard. As such, we were unable to
arbitrate differences between LUS and CXR ﬁndings. LUS cannot
detect consolidations that do not reach the pleura, whereas small
consolidations (<1 intercostal space) observed on LUS cannot be
visualized on CXR [27]. Nonetheless, the clinical relevance of small
consolidations of LUS remains uncertain. Moreover, retrocardiac
opaciﬁcations or consolidations may not be easily visualized on
antero-posterior CXRs when compared to LUS. Second, we did not
have information on the time course or severity of illness. Specifically, we did not follow the clinical course and had imaging only at
the time of enrollment. Third, LUS may not be able to differentiate
between small alveolar abnormalities and atelectasis. While Lichtenstein et al. described that, in adults, dynamic air bronchograms
were more likely to occur in pneumonia whereas static air bronchograms were more likely to occur in atelectasis [35], recognition
of dynamic air bronchograms is difﬁcult in children because of their
body size. Fourth, overall sensitivity of LUS for the diagnosis of
radiographically-conﬁrmed pneumonia was lower than previously
reported [15,16]. However, this may be in part due to selection bias
in previous studies where participants may have been more likely
to have severe pneumonia. It might also be due to probe placement
in our study: we did not consistently utilize transverse views,
which may improve the diagnostic yield in children [17]. Fifth, the
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study physician conducting the ultrasound was not blinded to
visible clinical symptoms, which may induce them to spend longer
conducting LUS on children that appear more ill. Sixth, the kappa
for agreement for CXR in our study was lower that what is previously found [36,37]. This may be due lack of adherence to the WHO
guidelines for reading CXRs, poor quality of the CXR and variability
of respiratory illness in our study population.
LUS is a promising tool that offers portability and diagnostic
accuracy in resource-limited settings. It has the added beneﬁts of
rapid testing and appears to be easily taught. These results offer
promise and may help improve the speciﬁcity of case management
algorithms for the diagnosis of pediatric pneumonia. Future
research should focus on prospective randomized trials using LUS
as part of the case management algorithm for acute lower respiratory infections. Moreover, with prospective follow-up, we may
better understand the evolution of LUS ﬁndings over time and
determine whether early diagnosis using LUS may translate into
clinically meaningful outcomes. Through increased development
and production of high performance, portable devices, and standardized training modules, LUS could be a cost-effective solution to
improve the diagnosis and management of pediatric pneumonia in
appropriate settings worldwide.
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